Outlook is where I'm honing in my interest:
- Revenue growth of 32.5% to 40%, $36m to $38m expected for FY22
- 60% of this growth is expected to come from international markets
- The major potential customers in UK and North America are progressing well
- One is a large global mining company with 30,000 users in final trial phase
Very positive outlook and I am hopeful of a positive rerate of the valuation for DTC based on the forward potential.
Wolf
- Forums
- ASX - By Stock
- DTC
- Ann: Damstra FY21 Financial Results
Ann: Damstra FY21 Financial Results, page-2
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DTC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online